Clinical Trials in Los Angeles

Showing 4101-4120 of 16,901 trials

High-quality COPD Care for People With Immune Dysfunction Through Proactive E-consults

NCT03856879

This study examines an intervention to promote effective, evidence-based care and de-implement inappropriate therapies for COPD in HIV-infected (HIV+) patients. The intervention facilitates specialist support of primary care, which includes infectious disease (ID) physicians who serve as the primary care providers (PCP) for their HIV+ patients in the ID clinic. Rather than relying on referral-driven specialty care which may be a barrier to access, pulmonologists will proactively support ID providers to manage a population of HIV+ patients with COPD, delivering real-time evidence-based recommendations tailored to the individual HIV+ patient in the form of an E-consult.

COPDHIV/AIDS

Seattle Institute for Biomedical and Clinical Research270 participantsStarted May 2019

Los Angeles, California, United States • Denver, Colorado, United States • New Haven, Connecticut, United States +4 more locations

COMPLETEDPhase 3< 1 mile

A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

NCT02684006

This is a phase 3 randomized trial evaluating the anti-tumor activity and safety of avelumab in combination with axitinib and of sunitinib monotherapy, administered as first-line treatment, in patients with advanced renal cell carcinoma

Renal Cell Cancer

Pfizer886 participantsStarted Mar 2016

Daphne, Alabama, United States • Mobile, Alabama, United States • Mobile, Alabama, United States +267 more locations

High-quality COPD Care for People With Immune Dysfunction Through Proactive E-consults

A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

Find Trials by Condition in Los Angeles

Adaptive Cell Phone Support (ACPS)

A Study of AGEN2034 in Advanced Tumors and Cervical Cancer

Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)

Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis

TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers

Applying Best Clinical Practices to Patients at High Risk of Respiratory Complications

A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

Enlighten Study: The EV-ICD Post Approval Registry

Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer

A Multi-Center Post-Market Data Collection Protocol to Evaluate the Performance of Orthofix Spine Devices

Optisure Lead Post Approval Study

Development and Validation of Harbinger Health Test for Early Cancer Detection

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

The Actuate-CBC Study

Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

A Long-term Follow-up Study of Patients Who Received VOR33

Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant

Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)